Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 99.10
-6.40 (-6.07%)
Jul 29, 2026, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 6.62 billion as of July 29, 2026. Its market cap has decreased by -33.71% in one year.
Market Cap
6.62B
Enterprise Value
4.32B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
99.10
ChartMarket Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 6.62B, an increase of 158.08%. That is a compound annual growth rate of 17.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 6.62B | -67.40% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grape King Bio | 13.47B |
| Foresee Pharmaceuticals | 12.45B |
| Standard Chemical & Pharmaceutical | 11.36B |
| Formosa Laboratories | 5.98B |
| SCI Pharmtech | 5.92B |
| Orient Pharma | 5.49B |
| Panion & Bf Biotech | 5.03B |
| Easywell Biomedicals | 4.41B |